瘤微环境通过纳米药物进行重编程,以增强瘤免疫疗法的效果
Yu Huang1, Hui Fan2, Huihui Ti1,3
1School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Asian journal of pharmaceutical sciences
|April 10, 2024
概括
瘤免疫疗法面临着由于免疫抑制性瘤微环境 (TME) 的挑战. 纳米医学提供了一个有希望的策略来重塑TME并提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米医学是一种纳米医学.
背景情况:
- 瘤免疫疗法显示出潜力,但受到免疫抑制性瘤微环境 (TME) 的限制.
- 特征为缺氧,低pH值和免疫抑制细胞的TME阻碍了有效的抗瘤免疫反应.
- 重塑TME对于提高免疫疗法的疗效至关重要.
研究的目的:
- 审查在癌症免疫治疗中改善瘤微环境 (TME) 的策略.
- 总结关于加强抗瘤免疫力的协同纳米医学方法的研究.
主要方法:
- 对TME调制和纳米医学在癌症免疫治疗中的应用现有文献的审查.
- 对纳米药物输送系统的分析,以准TME并提高药物的生物可用性.
- 通过纳米载体促进的多药组合的探索.
主要成果:
- 纳米医学可以有效地准和重塑免疫抑制的TME.
- 纳米药物载体增强了药物的生物可用性和向性,克服了传统药物输送的局限性.
- 协同纳米医学方法显示了对TME重编程和促进免疫治疗的潜力.
结论:
- 有效调节TME是克服免疫疗法耐药性的关键.
- 纳米医学为重新编程TME和推进癌症免疫疗法提供了一种新且强大的战略.
- 进一步研究以纳米医学为基础的TME重塑对改善癌症治疗结果具有重大前景.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.5K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
724
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522